Moreover, dorsomorphin sensitizes cancer cells to HSP90 inhibitor, downregulates the expression of HSP70, and induces apoptosis of cancer cells, positioning it as a potential therapeutic candidate in oncology (Table 1) 149. The gene discussed is HSP90AA1; the disease is cancer.